MediPharm Labs Corp. (TSX:LABS)
Canada
· Delayed Price · Currency is CAD 0.0900
+0.0150 (20.00%)
Apr 28, 2026, 3:56 PM EST
MediPharm Labs Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 10.81 | 11.69 | 17.98 | 24.15 | 34.11 | Upgrade
|
| Short-Term Investments | 0.56 | 0.19 | 0.27 | 0.76 | 1.14 | Upgrade
|
| Cash & Short-Term Investments | 11.37 | 11.88 | 18.25 | 24.9 | 35.25 | Upgrade
|
| Cash Growth | -4.27% | -34.92% | -26.73% | -29.36% | 60.46% | Upgrade
|
| Accounts Receivable | 6.77 | 6.88 | 5.52 | 12.35 | 15.72 | Upgrade
|
| Other Receivables | 0.76 | 0.63 | 0.35 | 0.66 | 1.2 | Upgrade
|
| Receivables | 7.53 | 7.51 | 5.87 | 13.01 | 16.92 | Upgrade
|
| Inventory | 7.85 | 8.56 | 9.89 | 7.78 | 10.98 | Upgrade
|
| Prepaid Expenses | 0.34 | 0.42 | 0.64 | 0.69 | 1.06 | Upgrade
|
| Other Current Assets | 0.38 | 4.71 | 2 | 0.98 | 1.34 | Upgrade
|
| Total Current Assets | 27.47 | 33.08 | 36.63 | 47.35 | 65.55 | Upgrade
|
| Property, Plant & Equipment | 17.6 | 19.16 | 25.27 | 18.11 | 25.89 | Upgrade
|
| Other Intangible Assets | 0.68 | 0.85 | 1.03 | 0.04 | 0.04 | Upgrade
|
| Other Long-Term Assets | - | 0.64 | 1 | - | 0.88 | Upgrade
|
| Total Assets | 45.74 | 53.73 | 63.94 | 65.5 | 92.36 | Upgrade
|
| Accounts Payable | 4.72 | 4.24 | 2.13 | 3.54 | 2.99 | Upgrade
|
| Accrued Expenses | 3.73 | 4.49 | 4.91 | 3.67 | 4.14 | Upgrade
|
| Short-Term Debt | 0.15 | 0.26 | 2.11 | 0.52 | - | Upgrade
|
| Current Portion of Leases | 0.05 | 0.08 | 0.12 | 0.08 | 0.11 | Upgrade
|
| Current Unearned Revenue | 0.57 | 0.61 | 0.39 | 0.49 | 1.32 | Upgrade
|
| Other Current Liabilities | 0.71 | 0.83 | 1.21 | 1.15 | 0.31 | Upgrade
|
| Total Current Liabilities | 9.93 | 10.5 | 10.86 | 9.46 | 8.88 | Upgrade
|
| Long-Term Leases | - | 0.05 | 0.07 | 0.03 | 0.1 | Upgrade
|
| Long-Term Unearned Revenue | - | - | - | - | 0.23 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | 0 | Upgrade
|
| Total Liabilities | 9.93 | 10.55 | 10.93 | 9.49 | 9.22 | Upgrade
|
| Common Stock | 201.9 | 201.21 | 200.24 | 191.26 | 190.55 | Upgrade
|
| Retained Earnings | -169.38 | -187.43 | -176.73 | -163.65 | -129.34 | Upgrade
|
| Comprehensive Income & Other | 3.29 | 29.4 | 29.49 | 28.4 | 21.94 | Upgrade
|
| Total Common Equity | 35.81 | 43.18 | 53.01 | 56.01 | 83.15 | Upgrade
|
| Shareholders' Equity | 35.81 | 43.18 | 53.01 | 56.01 | 83.15 | Upgrade
|
| Total Liabilities & Equity | 45.74 | 53.73 | 63.94 | 65.5 | 92.36 | Upgrade
|
| Total Debt | 0.2 | 0.39 | 2.3 | 0.63 | 0.22 | Upgrade
|
| Net Cash (Debt) | 11.17 | 11.49 | 15.95 | 24.27 | 35.04 | Upgrade
|
| Net Cash Growth | -2.79% | -27.99% | -34.27% | -30.73% | 897.86% | Upgrade
|
| Net Cash Per Share | 0.03 | 0.03 | 0.04 | 0.09 | 0.14 | Upgrade
|
| Filing Date Shares Outstanding | 424.86 | 415.14 | 404.05 | 282.16 | 273.94 | Upgrade
|
| Total Common Shares Outstanding | 424.86 | 415.05 | 401.4 | 282.16 | 273.54 | Upgrade
|
| Working Capital | 17.54 | 22.59 | 25.77 | 37.89 | 56.67 | Upgrade
|
| Book Value Per Share | 0.08 | 0.10 | 0.13 | 0.20 | 0.30 | Upgrade
|
| Tangible Book Value | 35.14 | 42.33 | 51.97 | 55.97 | 83.1 | Upgrade
|
| Tangible Book Value Per Share | 0.08 | 0.10 | 0.13 | 0.20 | 0.30 | Upgrade
|
| Land | 1.86 | 1.86 | 2.81 | 1.52 | 1.86 | Upgrade
|
| Buildings | 24.97 | 24.97 | 27.84 | 20.93 | 24.79 | Upgrade
|
| Machinery | 14.59 | 15.1 | 18.24 | 17.46 | 18.88 | Upgrade
|
| Construction In Progress | 0.01 | 0.05 | 2.5 | 2.6 | 4.49 | Upgrade
|
| Leasehold Improvements | 0.21 | 0.21 | 0.21 | 0.21 | 0.21 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.